You searched for Antibody candidate - Page 67 of 69

win horizon centauri antibody avvinity cancer alphamer

News and Trends 2 Mar 2016

New Joint Venture to Shake Up Immuno-Oncology in the UK

…treatments both for solid tumours and leukaemias. This is not an unusual strategy. In the past, Amgen bought Micromet’s antibody constructs, and AstraZeneca acquired Spirogen and their antibody ‘warheads‘. And…

March 2, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 16 Dec 2022

Astellas gastric cancer drug meets phase 3 primary endpoint

…that includes capecitabine and oxaliplatin). Zolbetuximab is an investigational first-in-class claudin-18.2 (CLDN18.2) targeted monoclonal antibody, for the first-line treatment of patients with CLDN18.2-positive, HER2-negative, locally advanced unresectable or metastatic gastric…

December 16, 2022 - 3 minutesmins - By Jim Cornall

alzheimers disease treatment vivoryon therapeutics

News and Trends 24 Oct 2019

German Alzheimer’s Drug Backed with €43M After Biogen’s Surprise Turnaround

…an upcoming European phase IIb trial of Vivoryon’s lead candidate small molecule drug in around 250 patients with Alzheimer’s disease, the most common form of dementia. Results are expected in…

October 24, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 28 Feb 2018

Yet Another Checkpoint Inhibitor Goes to Trial with Bavarian Nordic’s Cancer Vaccine

…BMS’s Opdivo, an antibody binds to the PD-1 receptor, in late 2016. They also partnered with Roche to test CV301 with Roche’s Tecentriq, an antibody which binds to the ligand…

February 28, 2018 - 3 minutesmins - By Alexander Burik

News and Trends 22 Jun 2022

Galapagos to acquire CellPoint and AboundBio to advance cell therapies

…an innovative, scalable, decentralized and automated point-of-care cell therapy supply model as well as a next-generation fully human antibody-based therapeutics platform. Galapagos said the goal is to expand the current…

June 22, 2022 - 5 minutesmins - By Jim Cornall

News and Trends 11 Jul 2022

Financing round of $21M completed for drug to treat autoimmune diseases

…entered into the worldwide agreement for the investigational anti-CD38 monoclonal antibody, CID-103, for the treatment, prevention, and diagnosis of autoimmune diseases, conditions, and disorders in humans. Strong activity CID-103 is…

July 11, 2022 - 3 minutesmins - By Liza Laws

Interview 21 May 2020

What 2019 Can Teach About European Biotech Investments Going Forward

…the Nasdaq Stock Exchange. The Danish company Genmab also pulled off a €450M Nasdaq IPO to fund the development of its antibody drug pipeline. In addition to these huge fundraises,…

May 21, 2020 - 9 minutesmins - By Jonathan Smith

In Depth 5 Dec 2022

The biggest private biotech investments in November 2022

…cheaply. Second place went to CatalYm in Germany. The firm specializes in the development of anti-cancer antibodies and is testing its lead candidate in clinical trials. Topping the healthcare biotech…

December 5, 2022 - 4 minutesmins - By Jonathan Smith

In Depth 26 Jun 2024

Biotech megadeals: Exploring the surge in $100M+ deals

…molecule therapies driving megadeals in the biotech industry. “The Inflation Reduction Act granted large molecule therapies (gene and protein-based therapies, immunotherapies, hormonal regulators, and antibody-drug conjugates), a much longer patent…

June 26, 2024 - 9 minutesmins - By Jules Adam

News and Trends 22 Jan 2018

Novartis Takes Genmab’s Leukemia Drug Off the Market

…a monoclonal antibody that targets CD20 proteins on the surface of leukemia cells. The antibody binds to the proteins, alerting the immune system, which can then hunt down and kill…

January 22, 2018 - 3 minutesmins - By Alex Dale

News and Trends 17 Nov 2016

Find Out what’s Hot in the Latin American Biotech scene

…and antibody specificity testing. In these areas, it has developed its MTB Array for Tuberculosis Proteome Microarray and FastMAb for custom antibody development. CDI is also pursuing a Protein Capture…

November 17, 2016 - 4 minutesmins - By External Contributor

Interview 12 Apr 2017

Video Interview: How Morphosys Grew Into a Billion-Euro Biotech

…biotech in Germany, Morphosys. Their topics ranged from Morphosys’ current pipeline and previous failures to the immuno-oncology hype and company culture. Morphosys started out with its proprietary antibody technology platform…

April 12, 2017 - 2 minutesmins - By Melanie De Almeida

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

New Joint Venture to Shake Up Immuno-Oncology in the UK

Astellas gastric cancer drug meets phase 3 primary endpoint

German Alzheimer’s Drug Backed with €43M After Biogen’s Surprise Turnaround

Yet Another Checkpoint Inhibitor Goes to Trial with Bavarian Nordic’s Cancer Vaccine

Galapagos to acquire CellPoint and AboundBio to advance cell therapies

Financing round of $21M completed for drug to treat autoimmune diseases

What 2019 Can Teach About European Biotech Investments Going Forward

The biggest private biotech investments in November 2022

Biotech megadeals: Exploring the surge in $100M+ deals

Novartis Takes Genmab’s Leukemia Drug Off the Market

Find Out what’s Hot in the Latin American Biotech scene

Video Interview: How Morphosys Grew Into a Billion-Euro Biotech

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!